Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > For those of you

<< Previous

Bullboard Posts

Next >>

Comment by Johnandrose22on Oct 04, 2023 9:01pm

248 Views

Post# 35670168

RE:RE:RE:RE:RE:RE:RE:RE:RE:For those of you

In principle, I would agree....Stock appreciation is often built upon not simply current clinical success but the anticipation of success.

Thus, the dilemma with TLT....With all of its remarkable milestones, outside of this board it seems, it has yet to garner any anticipatory passion/fervor from significant investors who look not simply at the present but into the possibilities to come.

I have no theories or answers for this. I can only shake my head sometimes.

John

<< Previous

Bullboard Posts

Next >>

Critical raw materials pioneer drives Europe’s clean energy transition